Cancer in Cystic Fibrosis: A Narrative Review of Prevalence, Risk Factors, Screening and Treatment Challenges

RECOMMENDED

Pulmonary Fibrosis

Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review

Thorax.

Rowbotham NJ, Smith S, Prayle AP, Robinson KA, Smyth AR

doi: 10.1136/thoraxjnl-

RECOMMENDED

Pulmonary Fibrosis

Duration of intravenous antibiotic treatment for acute exacerbations of cystic fibrosis: A systematic review: Duration of treatment for acute exacerbations of cystic fibrosis

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

J Cyst Fibros

Nicholson TT, Smith A, McKone EF, Gallagher CG

doi: 10.1016/j.jcf.2021.08.017

RECOMMENDED

Pulmonary Fibrosis

Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study

★ 2 Recommended by Dr Martin Frey, Faculty Member

J Cyst Fibros

Archangelidi O, Cullinan P, Simmonds NJ, Mentzakis E, Peckham D, Bilton D, Carr SB

doi: 10.1016/j.jcf.2021.07.004

Implementing the International Committee on Mental Health in Cystic Fibrosis (ICMH) guidelines: Screening accuracy and referral-treatment pathways

J Cyst Fibros.

Verkleij M, de Winter D, Hurley MA, Abbott J

doi: 10.1016/j.jcf.

Pulmonary Fibrosis

New treatments targeting the basic defects in cystic fibrosis

Presse Med.

Fajac I, Wainwright CE

doi: 10.1016/j.lpm.2017.01.024.

RECOMMENDED

Lung Cancer

Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer

★ 1 Recommended by Dr Martin Frey, Faculty Member

Clin Lung Cancer

Fisher A, Kim S, Farhat D, Belzer K, Milczuk M, French C, Mamdani H, Sukari A, Baciewicz F, Schwartz AG, Wozniak A, Nagasaka M

doi: 10.1016/j.cllc.2021.04.004

RECOMMENDED

AsthmaPulmonary Fibrosis

New treatments in respiratory medicine in 2018 : asthma, cystic fibrosis and nocturnal positive pressure (CPAP or NIV)

Rev Med Suisse.

Plojoux J, Charbonnier F, Janssens JP

RECOMMENDED

Further Publications

Performance of Risk factor-based Guidelines and Model-based Chest CT Lung Cancer Screening in World Trade Center Exposed Fire Department Rescue/Recovery Workers

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Chest

Cleven KL, Vaeth B, Zeig-Owens R, Colbeth HL, Jaber N, Schwartz T, Weiden MD, Markowitz SB, Silvestri GA, Prezant DJ

doi: 10.1016/j.chest.2020.11.028

COMMENTED

Inhaled mannitol for cystic fibrosis

Cochrane Database Syst Rev.

Nevitt SJ, Thornton J, Murray CS, Dwyer T

doi: 10.1002/14651858.

Related content

Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review

Duration of intravenous antibiotic treatment for acute exacerbations of cystic fibrosis: A systematic review: Duration of treatment for acute exacerbations of cystic fibrosis

Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study

Implementing the International Committee on Mental Health in Cystic Fibrosis (ICMH) guidelines: Screening accuracy and referral-treatment pathways

New treatments targeting the basic defects in cystic fibrosis

Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer

New treatments in respiratory medicine in 2018 : asthma, cystic fibrosis and nocturnal positive pressure (CPAP or NIV)

Performance of Risk factor-based Guidelines and Model-based Chest CT Lung Cancer Screening in World Trade Center Exposed Fire Department Rescue/Recovery Workers

Inhaled mannitol for cystic fibrosis